| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | CN101365456A Method for treating primary and secondary forms of glaucoma |
| 02/11/2009 | CN101365430A Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101361892A Traditional Chinese medicine formulation for treating cataract and preparation method thereof |
| 02/11/2009 | CN101361883A Medicine for treating the eye disease |
| 02/11/2009 | CN101361813A Rhubarb eyedrops |
| 02/11/2009 | CN100460874C Method for sieving crimp-relevant protain activator or antagonist |
| 02/10/2009 | US7488759 Malic acid addition salts of terbinafine |
| 02/10/2009 | US7488749 Therapy of diseases of the eye, the inner ear and the central nervous system |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | CA2385732C Bicyclic compounds composition and method for stabilizing the same |
| 02/10/2009 | CA2339299C Method of modulating memory effector t-cells and compositions |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/05/2009 | WO2009017259A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 02/05/2009 | WO2009017219A1 Inhibitor of binding of s1p1 |
| 02/05/2009 | WO2008137236A3 Treatment of age-related macular degeneration using inhibitors of complement factor d |
| 02/05/2009 | WO2008114114A3 Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition |
| 02/05/2009 | WO2008028032A4 Therapeutic substituted hydantoins and related compounds |
| 02/05/2009 | WO2003099808A8 Substituted heterocyclic compounds and methods of use |
| 02/05/2009 | US20090036761 Noninvasive measurement of chemical substances |
| 02/05/2009 | US20090036554 Ophthalmic compositions comprising a terpene compound |
| 02/05/2009 | US20090036552 Noninvasive Drug Delivery System To Tissue of Posterior Segment of Eye Using Solid Composition |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036479 Method of inhibiting choroidal neovascuarization |
| 02/05/2009 | US20090036464 Treatment Of Posterior Capsule Opacification |
| 02/05/2009 | US20090036412 Methods and Compositions for Inhibition of Angiogenesis |
| 02/05/2009 | US20090036405 Method for blocking ligation of the receptor for advanced glycation end-products (rage) |
| 02/05/2009 | US20090036404 Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof |
| 02/05/2009 | US20090036397 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
| 02/05/2009 | US20090036396 RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS |
| 02/05/2009 | US20090036371 Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents |
| 02/05/2009 | US20090035369 Composition and Methods for Treating and Preventing Age-Related Macular Degeneration |
| 02/05/2009 | US20090035279 Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | CA2723139A1 Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells |
| 02/05/2009 | CA2695384A1 Bi-dentate compounds as kinase inhibitors |
| 02/05/2009 | CA2693364A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2019834A1 Ectonucleotidase inhibitors |
| 02/04/2009 | EP2019820A1 Therapeutic pyrrolidine compounds |
| 02/04/2009 | CN101357177A Traditional Chinese medicine for preventing and treating central serous chorioretinopathy and preparation method thereof |
| 02/04/2009 | CN100457778C Mutant of ciliary nerves trophic factor (CNTF), producing method and usage |
| 02/04/2009 | CN100457777C Leucine-based motif and clostridial neurotoxins |
| 02/04/2009 | CN100457735C Therapeutic agents useful for treating pain |
| 02/04/2009 | CN100457151C Chinese goldthread soft capsule for clearing away adverse lung energy and its preparation process |
| 02/04/2009 | CN100457150C Capsule or tablet for relieving vision fatigue and preparing method |
| 02/04/2009 | CN100457131C Dripping pills of erigeron breviscapus and its preparation method |
| 02/04/2009 | CN100457111C Pharmaceutical uses of staurosporine derivatives |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485655 2-Aminothiazole allosteric enhancers of A1 adenosine receptors |
| 02/03/2009 | US7485654 Corneal perception recovery drug containing amide compound |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2392804C Combined agents for treatment of glaucoma |
| 02/03/2009 | CA2355359C Use of riluzole for treating acoustic traumas |
| 02/03/2009 | CA2185565C Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/29/2009 | WO2009014263A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/29/2009 | WO2009013435A2 Preservative-free prostaglandin-based ophthalmic solution |
| 01/29/2009 | US20090030188 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030182 Activatable recombinant neurotoxins |
| 01/29/2009 | US20090030085 Use of bis-amines to enhance the antimicrobial activity of aqueous compositions |
| 01/29/2009 | US20090030076 Prostaglandin derivatives |
| 01/29/2009 | US20090030001 Therapeutic agent for corneal disease |
| 01/29/2009 | US20090028955 Ophthalmic emulsions containing an immunosuppressive agent |
| 01/29/2009 | US20090028953 Method of treatment using microparticulate biomaterial composition |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/28/2009 | EP2018426A2 Rnai-mediated inhibition of tumor necrosis factor -related conditions |
| 01/28/2009 | EP2018103A2 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
| 01/28/2009 | EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 01/28/2009 | CN101353368A Pregna medicament for treating tumor |
| 01/28/2009 | CN101353366A Steroidal estrogen medicament for treating tumor |
| 01/28/2009 | CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof |
| 01/28/2009 | CN101352456A External-use medicament for treating blepharitis |
| 01/28/2009 | CN101352441A Brimonidine tartrate in situ forming eye gel |
| 01/28/2009 | CN101352439A Composition injection containing tetrandrine and preparation method thereof |
| 01/28/2009 | CN101352435A Use of lipoamide for preventing and treating age related macular degeneration |
| 01/28/2009 | CN101352409A Diclofenac sodium in situ forming eye gel |
| 01/28/2009 | CN101352408A Alficetin in situ forming eye gel |
| 01/28/2009 | CN100455599C Gene recombinant antibody and its fragment |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482328 an artificially synthesized antimicrobial polypeptide that does not occur in nature contains in its peptide chain one or more types of nuclear localization signal sequences (NLSs); for drug resistance bacteria |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/22/2009 | WO2009012075A1 Use of iop-lowering agents for treating primary and secondary forms of glaucoma |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009010871A2 Pyrazole derivatives as antagonists of adenosine a3 receptor |